(Q33732398)

English

A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149)

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149) (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Lode J Swinnen

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Cathryn Rankin

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Hetty Carraway

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Kathy S Albain

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Jeannette J Townsend

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

George Thomas Budd

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Julie A Kish

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Saul E Rivkin

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Deborah T Blumenthal

9

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

16 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

353-358

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

https://scigraph.springernature.com/pub.10.1007/s11060-007-9483-3

0 references

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

Synergistic interaction between 1-beta-D-arabinofuranosylcytosine, thymidine, and hydroxyurea against human B cells and leukemic blasts in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

Apurinic/apyrimidinic endonucleases in repair of pyrimidine dimers and other lesions in DNA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

Effect of cis-platinum(II)diamminodichloride on wild type and deoxyribonucleic acid repair deficient mutants of Escherichia coli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

Effect of 1-beta-D-arabinofuranosyl cytosine and hydroxyurea on the repair of X-ray-induced DNA single-strand breaks in human leukemic blasts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

Therapy of adult malignant brain tumors: what have the clinical trials taught us?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

1-beta-D-arabinofuranosylcytosine and hydroxyurea production of cytotoxic synergy with cis-diamminedichloroplatinum(II) and modification of platinum-induced DNA interstrand cross-linking

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

Cisplatin in the treatment of recurrent childhood primary brain tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

Cisplatin preceded by concurrent cytarabine and hydroxyurea: a pilot study based on an in vitro model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

Cytotoxic synergy of cisplatin with concurrent hydroxyurea and cytarabine: summary of an in vitro model and initial clinical pilot experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

Inhibition of DNA excision repair in human cells by arabinofuranosyl cytosine: effect on normal and xeroderma pigmentosum cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

The effect of cytosine arabinoside on the frequency of single-strand breaks in DNA of mammalian cells following irradiation or chemical treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

21 June 2018

Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9483-3

21 January 2018

Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteus

1 reference

https://api.crossref.org/works/10.1007%2FS11060-007-9483-3

21 January 2018

Cisplatin plus cytosine arabinoside in adults with malignant gliomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051205

30 October 2018

Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of anticancer platinum compounds on Escherichia coli strains with normal and defective DNA repair capacity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of deoxynucleoside triphosphate pools in the inhibition of DNA-excision repair and replication in human cells by hydroxyurea

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on mutagenesis and repair induced by platinum analogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18175205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-007-9483-3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33732398&oldid=1585833752"